Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis

Abstract

The relation between apolipoprotein (A PO E) gene polymorphisms and disease progression of multiple sclerosis (MS) is controversial. The present study was designed to investigate the relation between A PO E gene polymorphisms and Japanese patients with MS. We analysed the frequencies of A PO E gene polymorphisms in 135 MS patients and 134 healthy controls, using PC R-RFLP. The results showed no significant differences in the distribution of A PO E gene polymorphisms between MS patients and controls. With regard to disease progression, there was no association between A PO E gene polymorphisms and ε4 allele positivity and disease progression index (EDSS/years). Furthermore, in patients with more than 10 years of disease onset, there were no significant differences between the frequencies of ε4 allele and patients with EDSS of more than 6. A lthough the low rate of ε4 allele in Japan should be taken into consideration, our results showed no relation between APO E gene polymorphisms and Japanese patients with MS.

Keywords

apolipoprotein E ethnicity Japanese multiple sclerosis polymorphism prognosis

Get full access to this article

View all access options for this article.

References

Beffert U , Danik M , Krywkowski P , Ramassamy C , Berrada F , Poirier J. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer’s disease . Brain Res Brain Res Rev 1998; 27: 119-142 .

Laskowitz DT , Horsburgh K , Roses AD. Apolipoprotein E and the CNS response to injury . J Cereb Blood Flow Metab 1998; 18: 465-471 .

Roses AD , Saunders AM. ApoE, Alzheimer’s disease, and recovery from brain stress . Ann NY Acad Sci 1997; 826: 200-212 .

Stoll G , Meuller HW , Trapp BD , Griffin JW. Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve . Glia 1989; 2: 170-176 .

Gaillard O , Gervais A , Meillet D , Plassart E , Fontaine B , Lyon-Caen O et al. Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation . J Neurol Sci 1998; 158: 180-186 .

Rall SC Jr , Weisgraber KH , Mahley RW. Human apolipoprotein E. The complete amino acid sequence . J Biol Chem 1982; 257: 4171-4178 .

Chataway J , Feakes R , Coraddu F , Gray J , Deans J , Fraser M et al. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen . Brain 1998; 121: 1869-1887 .

Hogancamp WE , Rodriguez M , Weinshenker BG. identification of multiple sclerosis-associated genes . Mayo Clin Proc 1997; 72: 965-976 .

Weisgraber KH , Rall SC Jr , Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms . J Biol Chem 1981; 256: 9077-9083 .

10.

Hanis CL , Hewett-Emmett D , Douglas TC , Bertin TK , Schull WJ. Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas . Arterioscler Thromb 1991; 11: 362-370 .

11.

Nicoll JA , Roberts GW , Graham DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury . Nat Med 1995; 1: 135-137 .

12.

Breitner JC , Jarvik GP , Plassman BL , Saunders AM , Welsh KA. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years . Alzheimer Dis Assoc Disord 1998; 12: 40-44 .

13.

Ohm TG , Scharnagl H , Marz W , Bohl J. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer’s disease-related lesions . Acta Neuropathol (Berl) 1999; 98: 273-280 .

14.

Høgh P , Oturai A , Schreiber K , Blinkenberg M , Jorgensen OS , Ryder L et al. (2000) Apolipoprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate . Mult Scler 6: 226-230 .

15.

Gervais A , Gaillard O , Plassart E , Reboul J , Fontaine B , Schuller E. Apolipoprotein E polymorphism in multiple sclerosis . Ann Clin Biochem 1998; 35: 135-136 .

16.

Weatherby SJ , Mann CL , Davies MB , Carthy D , Fryer AA , Boggild MD et al. Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis . Mult Scler 2000; 6: 32-36 .

17.

Weatherby SJ , Mann CL , Fryer AA , Strange RC , Hawkins CP , Stevenson VL et al. No association between the APOE epsilon4 allele and outcome and susceptibility in primary progressive multiple sclerosis . J Neurol Neurosurg Psychiatry 2000; 68: 532-532 .

18.

Masterman T , Zhang Z , Hellgren D , Salter H , Anvret M , Lilius L et al. APOE genotypes and disease severity in multiple sclerosis . Mult Scler 2002; 8: 98-103 .

19.

Evangelou N , Jackson M , Beeson D , Palace J. Association of the APOE epsilon4 allele with disease activity in multiple sclerosis . J Neurol Neurosurg Psychiatry 1999; 67: 203-205 .

20.

Chapman J , Vinokurov S , Achiron A , Karussis DM , Mitosek-Szewczyk K , Birnbaum M et al. APOE genotype is a major predictor of long-term progression of disability in MS . Neurology 2001; 56: 312-316 .

21.

Fazekas F , Strasser-Fuchs S , Kollegger H , Berger T , Kristoferitsch W , Schmidt H et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis . Neurology 2001; 57: 853-857 .

22.

Hamilton AJ , Graham CA , Kirk CW , McDonnell GV et al. ApoE gene variants and a disease progression index in multiple sclerosis . Mult Scler 1999; 5: S34-S34 (Abstract).

23.

Ferri C , Sciacca FL , Veglia F , Martinelli F , Comi G , Canal N et al. APOE epsilon2-4 and -491 polymorphisms are not associated with MS . Neurology 1999; 53: 888-889 .

24.

Fazekas F , Strasser-Fuchs S , Schmidt H , Enzinger C , Ropele S , Lechner A et al. Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis . J Neurol Neurosurg Psychiatry 2000; 69: 25-28 .

25.

Ballerini C , Campani D , Rombola G , Gran B , Nacmias B , Pia Amato M et al. Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis . Neurosci Lett 2000; 296: 174-176 .

26.

McDonald WI , Compston A , Edan G , Goodkin D , Hartung HP , Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis . Ann Neurol 2001; 50: 121-127 .

27.

Fukazawa T , Miyasaka K , Tashiro K , Hamada T , Moriwaka F , Yanagihara T et al. MRI findings of multiple sclerosis with acute transverse myelopathy . J Neurol Sci 1992; 110: 27-31 .

28.

Fukazawa T , Hamada T , Moriwaka F , Tashiro K. Acute transverse myelopathy in MS: clinical considerations . Int MS J 1994; 1: 26-33 .

29.

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33: 1444-1452 .

30.

Hixson JE , Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I . J Lipid Res 1990; 31: 545-548 .

31.

Weinshenker BG. The natural history of multiple sclerosis. In Raine CS et al. eds. multiple Sclerosis. Clinical and pathogenetic basis. London: Chapman and Hall , 1997: 81-89.

32.

Ebers GC , Kukay K , Bulman DE , Sadovnick AD , Rice G , Anderson C et al. A full genome search in multiple sclerosis . Nat Genet 1996; 13: 472-476 .

33.

Haines JL , Ter-Minassian M , Bazyk A , Gusella JF , Kim DJ , Terwedow H et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group . Nat Genet 1996; 13: 469-471 .

34.

Sawcer S , Jones HB , Feakes R , Gray J , Smaldon N , Chataway J et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 . Nat Genet 1996; 13: 464-468 .

35.

Weinshenker BG. The natural history of multiple sclerosis . Neurol Clin 1995; 13: 119-146 .

36.

Kantarci OH , de Andrade M , Weinshenker BG. Identifying disease modifying genes in multiple sclerosis . J Neuroimmunol 2002; 123: 144-159 .

37.

Eto M , Watanabe K , Makino I. Increased frequencies of apolipoprotein epsilon 2 and epsilon 4 alleles in patients with ischemic heart disease . Clin Genet 1989; 36: 183-188 .

38.

Kokubo Y , Chowdhury AH , Date C , Yokoyama T , Sobue H , Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population . Stroke 2000; 31: 1299-1306 .

39.

Eichner JE , Dunn ST , Perveen G , Thompson DM , Stewart KE , Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review . Am J Epidemiol 2002; 155: 487-495 .

40.

Okinaka S , Reese HH , Katsuki S , Ueki K , Kuroiwa Y , Araki S et al. The prevalence of multiple sclerosis and other neurological diseases in Japan . Acta Neurol Scand 1966; 42 (Suppl 19): 68-76 .

41.

Yu YL , Woo E , Hawkins BR , Ho HC , Huang CY. Multiple sclerosis amongst Chinese in Hong Kong . Brain 1989; 112: 1445-1467 .

42.

Niino M , Fukazawa T , Yabe I , Kikuchi S , Sasaki H , Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles . J Neurol Sci 2000; 177: 65-71 .

43.

Niino M , Kikuchi S , Fukazawa T , Yabe I , Sasaki H , Tashiro K. Genetic polymorphisms of IL-1 and IL-1 receptor antagonist in association with multiple sclerosis in Japanese patients . J Neuroimmunol 2001; 118: 293-297 .

44.

Niino M , Kikuchi S , Fukazawa T , Yabe I , Tashiro K. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS . J Neuroimmunol 2002; 127: 177-179 .